TCL Archive FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness” September 3, 1976
TCL Archive NCI advisors approve recompetition of $62 million phase II contracts program. November 19, 2004
TCL Archive NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions. March 9, 2007